Skip to main content

GOLDMAN SACHS GROUP INC

Position in TGTX — Tg Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in TGTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$75,996,994
+$14,852,750 QoQ
Shares Held
2,287,688
+11.5% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Mar 31, 2026
CallValue
$7,972,800
CallShares
240,000
PutValue
$18,271,000
PutShares
550,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. TGTX ranks #36 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TGTX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,271,000 550,000
2026-03-31 $7,972,800 240,000
2026-03-31 $75,996,994 2,287,688
2025-12-31 $61,144,244 2,051,132
2025-09-30 $54,887,348 1,519,373
2025-06-30 $56,501,022 1,569,909
2025-03-31 $75,682,571 1,919,416
2024-12-31 $47,388,144 1,574,357
2024-09-30 $59,794,825 2,556,427
2024-06-30 $37,086,954 2,084,708
2024-03-31 $19,566,569 1,286,428
2023-12-31 $28,179,214 1,649,837
2023-09-30 $14,136,341 1,690,950
2023-06-30 $35,306,830 1,421,370
2023-03-31 $17,589,309 1,169,502
2022-12-31 $14,380,085 1,215,561
2022-09-30 $9,128,171 1,541,921
2022-06-30 $4,057,385 954,679
2022-03-31 $12,671,142 1,332,402
2021-12-31 $21,186,254 1,115,066
2021-09-30 $36,803,519 1,105,875
2021-06-30 $27,462,582 707,981
2021-03-31 $64,076,116 1,329,380
2020-12-31 $63,798,731 1,226,427
2020-09-30 $34,173,188 1,277,025
2020-06-30 $21,922,771 1,125,399
2020-03-31 $492,000 50,000
2020-03-31 $10,724,369 1,089,875